TIMASHEVA, Y.R.,
NASIBULLIN, T.R.,
MUSTAFINA, O.E.,
BALKHIYAROVA, Z.R.,
PROKOPENKO, I.,
AVZALETDINOVA, D.S.,
MORUGOVA, T.V. (2019) Background
Genome-wide association studies have captured a large proportion of
genetic variation
million
polymorphic risk markers for schizophrenia, significantly advancing our understanding
An association study was performed for
genetic polymorphisms in ADRB3 (rs4994) and ADRA2A (rs
Fedorova, Yu. Yu.,
Nurgalieva, A.K.,
Petrova, S.G.,
Murzina, R.R.,
Dzhaubermezov, M.A.,
Ekomasova, N.V.,
Khusnutdinova, E.K.,
Prokofieva, D.S. (2024) and controls. Determination of homocysteine levels and
genetic testing of MTHFR and MTRR
polymorphismsMolecular
genetic studies make it possible to determine associations of multifactorial diseases
Nurgalieva, A.Kh.,
Mustafin, S.A.,
Petrova, S.G.,
Ekomasova, N.V.,
Sakaeva, D.D.,
Fedorova, Y.Y.,
Abdeeva, G.R.,
Dzhaubermezov, M.A.,
Abdeev, R.R.,
Rakhimov, R.R.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2024) . It is assumed that
polymorphisms of the NFKB1 gene that disrupt its expression predispose to the development
of
polymorphic variants of inflammation genes with MetS and serum levels of high-sensitivity C-reactive protein
of
polymorphic markers in six chemokine
genes (CXCL13, CCL8, CCL16, CCL17, CCL18, and CCL23) was performed
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) blood indicators, identification of workers’
genetic status as per the rs1052133
polymorphic variant